Camlin Fine Sciences logo

CAMLINFINE - Camlin Fine Sciences Share Price

₹58.25 0.9  1.5%

Last Trade - 6:55am

Basic Materials
Small Cap
Market Cap £73.7m
Enterprise Value £124.9m
Revenue £111.2m
Position in Universe 749th / 2987
Unlock CAMLINFINE Revenue
Relative Strength (%)
1m +26.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -36.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
5,583 4,893 5,469 7,228 8,922 10,491 12,022 14,769 +13.4%
+82.4 -28.6 +5,582 +85.7 +54.0
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Camlin Fine Sciences Ltd revenues increased 18% to RS10.49B. Net income increased from RS5.8M to RS303.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Share of profit (loss) of associates and decrease of 98% to RS9K (expense). Basic Earnings per Share excluding Extraordinary Items increased from RS0.05 to RS2.50.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History



Net Income


Normalised EPS


PE Ratio Range


Dividend Yield Range

CAMLINFINE Dividend Yield Range Unlock CAMLINFINE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
Profile Summary

Camlin Fine Sciences Limited is engaged in fine chemicals business. The Company is a provider of antioxidants and shelf life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries across the world. Its products include BHA and TBHQ. The Company's offerings in shelf life solutions include XTENDRA, NASURE, REDOX, ENERSUPRA, RENDEROX, POLIACID and BIACID. It produces Catechol, the ingredient used to make Vanillin and Ethyl-Vanillin, that is used in a range of applications, such as bakery products, confectioneries, chocolates, supplements, milk, sweets, custard powder, masala incense stick, scented incense stick, pharma syrups, animal nutrition, chew tablets and laboratory chemicals. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, ODEB, CME, 4-MAP, Hydroquinone and Catechol.

Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated November 30, 1993
Public Since January 20, 2015
No. of Shareholders: n/a
No. of Employees: 322
Sector Basic Materials
Industry Chemicals
Exchange National Stock Exchange of India
Shares in Issue 121,254,000
Free Float (0.0%)
Eligible for
CAMLINFINE Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CAMLINFINE
Upcoming Events for CAMLINFINE
Saturday 25th July, 2020
Camlin Fine Sciences Ltd Extraordinary Shareholders Meeting
Monday 10th August, 2020
Camlin Fine Sciences Ltd Annual Shareholders Meeting
Frequently Asked Questions for Camlin Fine Sciences
What is the Camlin Fine Sciences share price?

As of 6:55am, shares in Camlin Fine Sciences are trading at ₹58.25, giving the company a market capitalisation of £73.7m. This share price information is delayed by 15 minutes.

How has the Camlin Fine Sciences share price performed this year?

Shares in Camlin Fine Sciences are currently trading at ₹58.25 and the price has moved by -1.2% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Camlin Fine Sciences price has moved by 6.37% over the past year.

What are the analyst and broker recommendations for Camlin Fine Sciences?

Of the analysts with advisory recommendations for Camlin Fine Sciences, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Camlin Fine Sciences is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Camlin Fine Sciences next release its financial results?

Camlin Fine Sciences is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Camlin Fine Sciences dividend yield?

Camlin Fine Sciences does not currently pay a dividend.

Does Camlin Fine Sciences pay a dividend?

Camlin Fine Sciences does not currently pay a dividend.

When does Camlin Fine Sciences next pay dividends?

Camlin Fine Sciences does not currently pay a dividend.

How do I buy Camlin Fine Sciences shares?

To buy shares in Camlin Fine Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Camlin Fine Sciences?

Shares in Camlin Fine Sciences are currently trading at ₹58.25, giving the company a market capitalisation of £73.7m.

Where are Camlin Fine Sciences shares listed? Where are Camlin Fine Sciences shares listed?

Here are the trading details for Camlin Fine Sciences:

Country of listing: India
Exchange: NSI
Ticker Symbol: CAMLINFINE
What kind of share is Camlin Fine Sciences?

Based on an overall assessment of its quality, value and momentum, Camlin Fine Sciences is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Camlin Fine Sciences share price forecast 2020?

Shares in Camlin Fine Sciences are currently priced at ₹58.25. At that level they are trading at 59.41% discount to the analyst consensus target price of 0.00.

Analysts covering Camlin Fine Sciences currently have a consensus Earnings Per Share (EPS) forecast of 4.643 for the next financial year.

How can I tell whether the Camlin Fine Sciences share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Camlin Fine Sciences. Over the past six months, the relative strength of its shares against the market has been -16.87%. At the current price of ₹58.25, shares in Camlin Fine Sciences are trading at -1.23% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Camlin Fine Sciences PE Ratio?

The Camlin Fine Sciences PE ratio based on its reported earnings over the past 12 months is 22.96. The shares are currently trading at ₹58.25.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Camlin Fine Sciences?

Camlin Fine Sciences's management team is headed by:

Dilip Dandekar - NEC
Ashish Dandekar - MDR
Dattatraya Puranik - CFO
Nirmal Momaya - NED
Ajit Deshmukh - NED
Anagha Dandekar - NED
Arjun Dukane - EDR
Sutapa Banerjee - IND
Mondor Godbole - CCO
Who are the major shareholders of Camlin Fine Sciences?

Here are the top five shareholders of Camlin Fine Sciences based on the size of their shareholding:

Dandekar (Ashish Subhash) Individual Investor
Percentage owned: 11.6% (14.1m shares)
SBI Funds Management Pvt. Ltd. Investment Advisor
Percentage owned: 8.85% (10.7m shares)
SBI Magnum Multicap Fund Mutual Fund
Percentage owned: 7.05% (8.55m shares)
ICICI Prudential Asset Management Co. Ltd. Investment Advisor
Percentage owned: 5.79% (7.01m shares)
Camart Industries, Ltd. Corporation
Percentage owned: 4.39% (5.32m shares)
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.